Oarsman Capital’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $613K | Sell |
|
|||||
|
2025
Q2 | $614K | Sell |
|
|||||
|
2025
Q1 | $597K | Sell |
|
|||||
|
2024
Q4 | $545K | Sell |
|
|||||
|
2024
Q3 | $670K | Sell |
|
|||||
|
2024
Q2 | $624K | Sell |
|
|||||
|
2024
Q1 | $598K | Sell |
|
|||||
|
2023
Q4 | $638K | Buy |
|
|||||
|
2023
Q3 | $633K | Sell |
|
|||||
|
2023
Q2 | $634K | Sell |
|
|||||
|
2023
Q1 | $596K | Sell |
|
|||||
|
2022
Q4 | $616K | Sell |
|
|||||
|
2022
Q3 | $544K | Sell |
|
|||||
|
2022
Q2 | $625K | Sell |
|
|||||
|
2022
Q1 | $709K | Buy |
|
|||||
|
2021
Q4 | $659K | Sell |
|
|||||
|
2021
Q3 | $681K | Sell |
|
|||||
|
2021
Q2 | $797K | Sell |
|
|||||
|
2021
Q1 | $1.63M | Sell |
|
|||||
|
2020
Q4 | $2.27M | Sell |
|
|||||
|
2020
Q3 | $2.12M | Sell |
|
|||||
|
2020
Q2 | $2.34M | Buy |
|
|||||
|
2020
Q1 | $949K | Sell |
|
|||||
|
2019
Q4 | $2.1M | Buy |
|
|||||
|
2019
Q3 | $1.1M | Sell |
|
|||||
|
2019
Q2 | $1.17M | Sell |
|
|||||
|
2019
Q1 | $1.24M | Sell |
|
|||||
|
2018
Q4 | $1.13M | Sell |
|
|||||
|
2018
Q3 | $1.15M | Sell |
|
|||||
|
2018
Q2 | $1.02M | Buy |
|
|||||
|
2018
Q1 | $962K | Buy |
|
|||||
|
2017
Q4 | $990K | Sell |
|
|||||
|
2017
Q3 | $1.03M | Sell |
|
|||||
|
2017
Q2 | $1.02M | Sell |
|
|||||
|
2017
Q1 | $929K | Sell |
|
|||||
|
2016
Q4 | $977K | Sell |
|
|||||
|
2016
Q3 | $1.25M | Sell |
|
|||||
|
2016
Q2 | $1.36M | Sell |
|
|||||
|
2016
Q1 | $1.23M | Buy |
|
|||||
|
2015
Q4 | $1.46M | Buy |
|
|||||
|
2015
Q3 | $1.55M | Buy |
|
|||||
|
2015
Q2 | $1.65M | Sell |
|
|||||
|
2015
Q1 | $1.69M | Sell |
|
|||||
|
2014
Q4 | $1.59M | Sell |
|
|||||
|
2014
Q3 | $1.63M | Buy |
|
|||||
|
2014
Q2 | $1.57M | Sell |
|
|||||
|
2014
Q1 | $1.47M | Sell |
|
|||||
|
2013
Q4 | $1.41M | Buy |
|
|||||
|
2013
Q3 | $1.34M | Buy |
|
|||||
|
2013
Q2 | $1.21M | Buy |
|